Drug Pricing Analysis: ICER’s Launch Pric...

By João L. Carapinha

May 20, 2025

The Institute for Clinical and Economic Review (ICER) has published the protocol for its first annual "Launch Price and Access Report." This essential drug pricing analysis evaluates launch prices and patient access to FDA-approved drugs from 2022...
Trends in Anticancer Drug Pricing: Analyzing Medicare Launch Prices and Impac...
A System Dynamics Approach to Lowering Drug Prices by 30–80% in the US
EFPIA Advocates for Stronger Life Sciences in EU Multiannual Financial Framework
Evolving NICE Health Technology Evaluations: Enhancing Patient Perspectives a...
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
Revolutionizing Hepatitis C Treatment: The Transformative Role of Direct-Acti...
MR-107A-02: Revolutionizing Non-Opioid Pain Management with Viatris’ Breakthr...
Prevention Valuation: Fund Health, Not Just Savings
FDA AI Drug Approval
Trump Science Publishing Critique: Analyzing Political Interference and Metho...
South Africa NHI Bill Court Ruling Calls for Scrutiny
Implementing Health Technology Assessment in Oman